SG11202108840XA - Producing compositions comprising two or more antibodies. - Google Patents

Producing compositions comprising two or more antibodies.

Info

Publication number
SG11202108840XA
SG11202108840XA SG11202108840XA SG11202108840XA SG11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA
Authority
SG
Singapore
Prior art keywords
antibodies
producing compositions
compositions
producing
Prior art date
Application number
SG11202108840XA
Other languages
English (en)
Inventor
Robert Paul Doornbos
Alexander Berthold Hendrik Bakker
Original Assignee
Merus Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merus Nv filed Critical Merus Nv
Publication of SG11202108840XA publication Critical patent/SG11202108840XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/526—CH3 domain
SG11202108840XA 2019-02-14 2020-02-13 Producing compositions comprising two or more antibodies. SG11202108840XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19157286 2019-02-14
EP19178542 2019-06-05
PCT/NL2020/050080 WO2020167122A1 (en) 2019-02-14 2020-02-13 Producing compositions comprising two or more antibodies.

Publications (1)

Publication Number Publication Date
SG11202108840XA true SG11202108840XA (en) 2021-09-29

Family

ID=69771002

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108840XA SG11202108840XA (en) 2019-02-14 2020-02-13 Producing compositions comprising two or more antibodies.

Country Status (13)

Country Link
US (1) US20220127375A1 (es)
EP (1) EP3924377A1 (es)
JP (2) JP7375027B2 (es)
KR (1) KR20210126699A (es)
AU (1) AU2020221649A1 (es)
BR (1) BR112021016092A2 (es)
CA (1) CA3130246A1 (es)
IL (1) IL285489A (es)
MA (1) MA54943A (es)
MX (1) MX2021009769A (es)
SG (1) SG11202108840XA (es)
TW (1) TW202045132A (es)
WO (1) WO2020167122A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201920275A (zh) * 2017-07-06 2019-06-01 荷蘭商米樂斯股份有限公司 藉由細胞表現之調控生物活性的抗體
US20220281914A1 (en) * 2020-12-18 2022-09-08 Kiniksa Pharmaceuticals, Ltd. Protein compositions and methods for producing and using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856324A (zh) * 2002-09-17 2006-11-01 Gtc生物治疗学公司 缺乏重链间二硫键的免疫球蛋白分子的分离
CA2527694C (en) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
EP2471816A1 (en) 2006-08-30 2012-07-04 Genentech, Inc. Multispecific antibodies
EP2147594B1 (en) 2008-06-27 2013-11-13 Merus B.V. Antibody producing non-human mammals
ES2572728T3 (es) 2009-03-20 2016-06-02 F. Hoffmann-La Roche Ag Anticuerpos anti-HER biespecíficos
RU2606264C2 (ru) * 2009-12-25 2017-01-10 Чугаи Сеияку Кабушики Каиша Способ полипептидной модификации для очистки полипептидных мультимеров
MX360109B (es) 2012-04-20 2018-10-23 Merus Nv Metodos y medios para la produccion de moleculas de tipo ig.
EP3036253B1 (en) * 2013-08-19 2020-09-23 F. Hoffmann-La Roche AG Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography
AU2018279278A1 (en) * 2017-06-05 2019-12-19 Janssen Biotech, Inc. Methods of engineering surface charge for bispecific antibody production

Also Published As

Publication number Publication date
MA54943A (fr) 2021-12-22
TW202045132A (zh) 2020-12-16
EP3924377A1 (en) 2021-12-22
US20220127375A1 (en) 2022-04-28
JP7375027B2 (ja) 2023-11-07
IL285489A (en) 2021-09-30
CA3130246A1 (en) 2020-08-20
AU2020221649A1 (en) 2021-09-02
BR112021016092A2 (pt) 2021-10-26
JP2023171492A (ja) 2023-12-01
JP2022520972A (ja) 2022-04-04
MX2021009769A (es) 2021-09-08
WO2020167122A1 (en) 2020-08-20
KR20210126699A (ko) 2021-10-20

Similar Documents

Publication Publication Date Title
IL277072A (en) Anti-claudin antibodies 18.2
MX2019007021A (es) Anticuerpos il-11ra.
EP4017883A4 (en) NEW ANTI-CLDN18.2 ANTIBODIES
SG11202108141VA (en) Novel cd40-binding antibodies
IL289112A (en) Antibodies against tigit
IL283754A (en) Anti-claudin antibodies, preparations containing them and their uses
IL280809B (en) New preparations, their use and methods of their creation
IL285651A (en) Anti-trem2 antibodies, preparations containing them and their uses
IL291068A (en) Anti-cd73 antibodies
EP3692072A4 (en) ANTI-HLA-DQ2.5 ANTIBODIES
WO2017011340A3 (en) Proteins and immunizing compositions containing klebsiella proteins and methods of use
WO2017021539A3 (en) Novel anti-human gpvi antibodies and uses thereof
IL284584A (en) Anti-tigit antibodies
IL284800A (en) Methods, uses and compositions
IL287828A (en) Anti-epha4 antibody
IL285489A (en) Production of preparations containing two or more antibodies
EP3947466A4 (en) ANTI-HLA-DQ2.5 ANTIBODIES
GB201905150D0 (en) Ant-ige antibodies
GB201917480D0 (en) Antibodies
EP3858994A4 (en) ANTIBODY COMPOSITION
GB201900732D0 (en) Antibodies
IL289160A (en) Anti-angpt2 antibodies
GB202015822D0 (en) 66.123.142648/01
EP4081546A4 (en) NEW ANTI-FGFR2B ANTIBODIES
EP4081547A4 (en) NOVEL ANTI-FGFR2B ANTIBODIES